lauric acid

Small moleculeexperimental

Lauric acid, or dodecanoic acid, is the main acid in coconut oil and in palm kernel oil, and is believed to have antimicrobial properties. The detected values of half maximal effective concentration (EC(50)) of lauric acid on P. acnes, S. aureus, and S. epidermidis growth indicate that P. acnes is the most sensitive to lauric acid among these bacteria. In addition, lauric acid did not induce cytotoxicity to human sebocytes. This data highlight the potential of using lauric acid as an alternative treatment for antibiotic therapy of acne vulgaris. Lauric acid is used in the manufacture of soaps, detergents, cosmetics, and lauryl alcohol. — NCATS

Clinical trial activity

6 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Sep 1, 1996 (NCT00004690)

Timeline

1990s

  1. Jan 1, 1996

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2016

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCCCCCCCCCCC(O)=O
Mol. weight
200.3178 g/mol

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1-dodecylglycerol
  • 1-o-dodecylglycerol
  • dodecanoic acid, monoester with 1,2,3-propanetriol
  • glycerol monolaurate
  • lauricidin
  • monododecylglycerol
  • monoglycerol laurate
  • monolaurin
  • monolaurin
  • monolaurin
  • rac-sn-1(3)-dodecylglycerol

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06046937Early Phase 1 (Phase 1)Jun 1, 2023Victoriano Luna Medical Center
NCT05602324N/AOct 1, 2021University of British Columbia
NCT04292236N/AFeb 22, 2019University of London
NCT02709005Phase 2Apr 14, 2016National Institute of Allergy and Infectious Diseases (NIAID)
NCT02772458N/AJun 30, 2015University of Nottingham
NCT00004690Phase 3Sep 1, 1996Cellegy Pharmaceuticals
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cellegy PharmaceuticalsFor profit1111996
National Institute of Allergy and Infectious Diseases (NIAID)Government1112016
University of British ColumbiaAcademic/Hospital1112021
University of LondonAcademic/Hospital1112019
University of NottinghamAcademic/Hospital1112015
Victoriano Luna Medical CenterAcademic/Hospital1112023
6 organizations
Page 1 / 1